Cite
HARVARD Citation
Burmester, G. et al. (2009). Adalimumab safety and mortality rates from global clinical trials of six immune-mediated inflammatory diseases. Annals of the rheumatic diseases. 68 (12), pp. 1863-1869. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Burmester, G. et al. (2009). Adalimumab safety and mortality rates from global clinical trials of six immune-mediated inflammatory diseases. Annals of the rheumatic diseases. 68 (12), pp. 1863-1869. [Online].